Alpha Teknova Inc (TKNO) stock price

Alpha Teknova Inc (TKNO) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $7.79 (+4.56%), Market cap $0.19B, 52-week low–high $1.99 ~ $7.06.

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Alpha Teknova Inc are updated in real time on BlackAll Trade.

Alpha Teknova Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Alpha Teknova Inc (TKNO) stock price?

Alpha Teknova Inc trades at $7.79 (+4.56%). Real-time quotes and charts are available on BlackAll Trade.

What is the Alpha Teknova Inc (TKNO) market cap?

Alpha Teknova Inc has a market cap of about $0.19B.

What does Alpha Teknova Inc (TKNO) do?

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. T